School of Medicine

Showing 1-4 of 4 Results

  • Maximilian Diehn, MD, PhD

    Maximilian Diehn, MD, PhD

    Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)

    Current Research and Scholarly InterestsMy laboratory focuses on two main areas: 1) cancer stem cell biology and 2) novel biomarkers for identifying the presence of malignant cells (diagnostic), predicting outcome (prognostic), and predicting response to therapy (predictive). Areas of study include cancers of the lung, breast, and gastrointestinal system. Clinically I specialize in the treatment of lung cancer and applications of stereotactic ablative radiotherapy and perform both prospective and retrospective clinical studies.

  • Sarah S. Donaldson, MD

    Sarah S. Donaldson, MD

    Catharine and Howard Avery Professor in the School of Medicine, Emerita

    Current Research and Scholarly InterestsCombined Modality Treatment of Cancer
    Late Effects of Treatment
    Genetic Effects of Cancer
    Hodgkins Disease
    Pediatric Radiation Oncolgy
    Pediatric Oncolgy
    Breast Cancer
    Conformal Radiotherapy/IMRT
    Radiotherapy for Benign Diseases

  • Michael Louis Dworkin

    Michael Louis Dworkin

    Affiliate, Dean's Office Operations - Dean Other
    Resident in Radiation Oncology - Radiation Therapy

    BioDr. Dworkin graduated from The Ohio State University in 2012, where he studied mathematics and was inducted into Phi Beta Kappa. There, he developed a research interest in systems biology and oncology and won a Pelotonia Undergraduate Cancer Research Fellowship. He received his MD from Duke University School of Medicine in 2018. During medical school, he developed an interest in radiation oncology and researched psuedoprogression in patients with low-grade gliomas treated with proton radiotherapy. He completed a preliminary internal medicine internship at University of Kentucky in 2019. Currently, he is a resident physician in the Department of Radiation Oncology at Stanford. His work at Stanford has led to several abstracts and a first-authored publication on the use of a radiotherapy boost in patients undergoing hematopoietic stem cell transplant. He is interested in a career in academic radiation oncology focused on the development and implementation of radiobiologically informed and innovative radiotherapy treatment approaches and technologies that aim to deliver effective treatment while minimizing burden to patients with cancer.